Feasibility of Early Gabapentin as an Intervention for Neurorecovery

PHASE4RecruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 14, 2022

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Spinal Cord Injuries
Interventions
DRUG

Gabapentin

Generic gabapentin

DRUG

Placebo

Inert cellulose

Trial Locations (1)

44109

RECRUITING

MetroHealth Medical Center, Cleveland

All Listed Sponsors
collaborator

National Institute on Disability, Independent Living, and Rehabilitation Research

FED

lead

MetroHealth Medical Center

OTHER